CAR-T Meeting 2023 | Unmet needs in CAR-T therapy: options for patients who progress during the manufacturing process
Nina Worel
• 9 Feb 2023
Nina Worel, MD, Medical University of Vienna, Vienna, Austria, briefly discusses the challenge of providing suitable options for patients who progress during the CAR-T manufacturing process, and comments on the importance of controlling the disease before continuing with treatment. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
